Changes in body composition as assessed by DXA scan after one year of high dose growth hormone treatment in children born SGA. Results from the NESGAS group

被引：0
|
作者：
O'Connell, Susan M. [1 ,2 ]
Jensen, Rikke Beck [3 ]
Salgin, Burak [4 ]
O'Mullane, Elaine [1 ]
Kirk, Jeremy [5 ]
Donaldson, Malcolm [6 ]
Ivarsson, Sten [7 ]
Soder, Olle [8 ,9 ]
Dunger, David B. [4 ]
Juul, Anders [3 ]
Hoey, Hilary M. C. V. [1 ,2 ]
机构：
[1] Natl Childrens Hosp, Dublin, Ireland
[2] Univ Dublin Trinity Coll, Dublin 2, Ireland
[3] Rigshosp, DK-2100 Copenhagen, Denmark
[4] Univ Cambridge, Addenbrookes Hosp, Cambridge CB2 2QQ, England
[5] Birmingham Childrens Hosp, Birmingham, W Midlands, England
[6] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland
[7] Univ Sjukhuset MAS, Malmo, Sweden
[8] Karolinska Inst, Pediat Endocrinol Unit, Stockholm, Sweden
[9] Univ Hosp, Stockholm, Sweden
来源：
HORMONE RESEARCH | 2009年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：445 / 445
页数：1
相关论文
共 26 条
  • [21] Age and Severity of Growth Retardation at Treatment Start, but Not Degree of Prematurity or IUGR Are Related to One and Two Year GH Treatment Response in Short Children Born SGA: Data from the Nordinet® IOS and ANSWER® Program.
    Lee, Peter A.
    Blankenstein, Oliver
    Pienkowski, Catherine
    Oliver, Isabelle
    Snajderova, Marta
    Rakov, Viatcheslav
    Pedersen, Birgitte T.
    Germak, John
    Savendahl, Lars
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [22] Insulin-like growth factor-I, d3-GHR gene polymorphism, prematurity and height at start as determinants of one year growth response during high dose GH; preliminary results from the NESGA study (NESGAS)
    Jensen, Rikke B.
    O'Connell, Susan
    Salgin, Burak
    Kirk, Jeremy
    Donaldson, Malcolm
    Ivarsson, Sten
    Soder, Olle
    Hoey, Hilary
    Dunger, David B.
    Juul, Anders
    HORMONE RESEARCH, 2009, 72 : 440 - 440
  • [23] In children suffering from juvenile idiopathic arthritis, RHGH treatment, started one year after the initiation of glucocorticoid therapy prevents growth retardation and increases lean body mass: Results of a 3-year randomised controlled study
    Simon, D.
    Ruiz, J.
    Prieur, A.
    Czernichow, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 568 - 568
  • [24] Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: Results of a randomized, double-blind, dose-response GH trial
    van Pareren, Y
    Mulder, P
    Houdijk, M
    Jansen, M
    Reeser, M
    Hokken-Koelega, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08): : 3584 - 3590
  • [25] Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial
    Willemsen, Ruben H.
    Arends, Nicolette J. T.
    Waarde, Willie M. Bakker-van
    Jansen, Maarten
    van Mil, Edgar G. A. H.
    Mulder, Jaap
    Odink, Roelof J.
    Reeser, Maarten
    Rongen-Westerlaken, Ciska
    Stokvis-Brantsma, Wilhelmina H.
    Waelkens, Johan J. J.
    Hokken-Koelega, Anita C. S.
    CLINICAL ENDOCRINOLOGY, 2007, 67 (04) : 485 - 492
  • [26] D3-growth hormone receptor polymorphism (d3-GHR) does not influence the effect of GH treatment in prepubertal short SGA children: results from a two-year controlled prospective trial in 68 GH-treated and 72 non GH-treated patients
    Carrascosa, Antonio
    Esteban, Cristina
    Espadero, Rosa
    Cancio, Monica Fernandez
    Andaluz, Pilar
    Clemente, Maria
    Audi, Laura
    Wollmann, Hartmut
    Frykund, Linda
    Parodi, Luis A.
    HORMONE RESEARCH, 2006, 65 : 153 - 153
123